Antonio B Fernandez1, Maria Carmo P Nunes2, Eva H Clark3, Aaron Samuels4, Silvio Menacho5, Jesus Gomez6, Ricardo W Bozo Gutierrez7, Thomas C Crawford8, Robert H Gilman9, Caryn Bern10. 1. Division of Cardiology, Hartford Hospital and University of Connecticut School of Medicine, Hartford, CT, USA. Electronic address: antoinefernandezt@hotmail.com. 2. School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil. 3. Baylor College of Medicine, Houston, TX, USA. 4. Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. Centro de Salud, Eity, Gutierrez, Bolivia. 6. Hospital San Juan de Dios, Santa Cruz, Bolivia. 7. Hospital Municipal Camiri, Camiri, Bolivia. 8. Department of Cardiology, University of Michigan Health System, Ann Arbor, MI, USA. 9. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 10. Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Abstract
BACKGROUND: Chagas disease is a neglected and preventable tropical disease that causes significant cardiac morbidity and mortality in Latin America. OBJECTIVES: This study sought to describe cardiac findings among inhabitants of rural communities of the Bolivian Chaco. METHODS: The cardiac study drew participants from an epidemiologic study in 7 indigenous Guarani communities. All infected participants 10 years or older were asked to undergo a brief physical examination and 12-lead electrocardiogram (ECG). A subset had echocardiograms. ECG and echocardiograms were read by 1 or more cardiologists. RESULTS: Of 1,137 residents 10 years or older, 753 (66.2%) had Trypanosoma cruzi infection. Cardiac evaluations were performed for 398 infected participants 10 years or older. Fifty-five participants (13.8%) had 1 or more ECG abnormalities suggestive of Chagas cardiomyopathy. The most frequent abnormalities were bundle branch blocks in 42 (11.3%), followed by rhythm disturbances or ventricular ectopy in 13 (3.3%), and atrioventricular blocks (AVB) in 10 participants (2.6%). The prevalence of any abnormality rose from 1.1% among those 10 to 19 years old to 14.2%, 17.3%, and 26.4% among those 20 to 39, 40 to 59, and older than 60 years, respectively. First-degree AVB was seen most frequently in participants 60 years or older, but the 4 patients with third-degree AVB were all under 50 years old. Eighteen and 2 participants had a left ventricular ejection fraction of 40% to 54% and <40%, respectively. An increasing number of ECG abnormalities was associated with progressively larger left ventricular end-diastolic dimensions and lower left ventricular ejection fraction. CONCLUSIONS: We found a high prevalence of ECG abnormalities and substantial evidence of Chagas cardiomyopathy. Programs to improve access to basic cardiac care (annual ECG, antiarrhythmics, pacemakers) could have an immediate impact on morbidity and mortality in these highly endemic communities.
BACKGROUND:Chagas disease is a neglected and preventable tropical disease that causes significant cardiac morbidity and mortality in Latin America. OBJECTIVES: This study sought to describe cardiac findings among inhabitants of rural communities of the Bolivian Chaco. METHODS: The cardiac study drew participants from an epidemiologic study in 7 indigenous Guarani communities. All infected participants 10 years or older were asked to undergo a brief physical examination and 12-lead electrocardiogram (ECG). A subset had echocardiograms. ECG and echocardiograms were read by 1 or more cardiologists. RESULTS: Of 1,137 residents 10 years or older, 753 (66.2%) had Trypanosoma cruzi infection. Cardiac evaluations were performed for 398 infected participants 10 years or older. Fifty-five participants (13.8%) had 1 or more ECG abnormalities suggestive of Chagas cardiomyopathy. The most frequent abnormalities were bundle branch blocks in 42 (11.3%), followed by rhythm disturbances or ventricular ectopy in 13 (3.3%), and atrioventricular blocks (AVB) in 10 participants (2.6%). The prevalence of any abnormality rose from 1.1% among those 10 to 19 years old to 14.2%, 17.3%, and 26.4% among those 20 to 39, 40 to 59, and older than 60 years, respectively. First-degree AVB was seen most frequently in participants 60 years or older, but the 4 patients with third-degree AVB were all under 50 years old. Eighteen and 2 participants had a left ventricular ejection fraction of 40% to 54% and <40%, respectively. An increasing number of ECG abnormalities was associated with progressively larger left ventricular end-diastolic dimensions and lower left ventricular ejection fraction. CONCLUSIONS: We found a high prevalence of ECG abnormalities and substantial evidence of Chagas cardiomyopathy. Programs to improve access to basic cardiac care (annual ECG, antiarrhythmics, pacemakers) could have an immediate impact on morbidity and mortality in these highly endemic communities.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: J O Lázzari; M Pereira; C M Antunes; A Guimarães; A Moncayo; R Chávez Domínguez; O Hernández Pieretti; V Macedo; A Rassi; J Maguire; A Romero Journal: Rev Panam Salud Publica Date: 1998-11
Authors: Anis Rassi; Anis Rassi; William C Little; Sérgio S Xavier; Sérgio G Rassi; Alexandre G Rassi; Gustavo G Rassi; Alejandro Hasslocher-Moreno; Andrea S Sousa; Maurício I Scanavacca Journal: N Engl J Med Date: 2006-08-24 Impact factor: 91.245
Authors: S Williams-Blangero; T Magalhaes; E Rainwater; J Blangero; R Corrêa-Oliveira; J L Vandeberg Journal: Am J Trop Med Hyg Date: 2007-09 Impact factor: 2.345
Authors: Caryn Bern; Susan P Montgomery; Barbara L Herwaldt; Anis Rassi; Jose Antonio Marin-Neto; Roberto O Dantas; James H Maguire; Harry Acquatella; Carlos Morillo; Louis V Kirchhoff; Robert H Gilman; Pedro A Reyes; Roberto Salvatella; Anne C Moore Journal: JAMA Date: 2007-11-14 Impact factor: 56.272
Authors: Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy Journal: PLoS Negl Trop Dis Date: 2013-02-28
Authors: Pablo L Santo-Orihuela; Claudia V Vassena; Guillermo Carvajal; Eva Clark; Silvio Menacho; Ricardo Bozo; Robert H Gilman; Caryn Bern; Paula L Marcet Journal: J Med Entomol Date: 2017-01-01 Impact factor: 2.278
Authors: Elena Refoyo; Jesús Troya; Elena Trigo; Gabriela Guzmán-Martinez; Silvia Valbuena-López; Juan Caro-Codón; Sandra Rosillo; Mar Moreno-Yanguela; Juan Tamargo; José Ramón Arribas; Harry Acquatella; José Lopez-Sendon Journal: Am J Trop Med Hyg Date: 2020-10 Impact factor: 3.707
Authors: Steven J Clipman; Josephine Henderson-Frost; Katherine Y Fu; Caryn Bern; Jorge Flores; Robert H Gilman Journal: PLoS One Date: 2018-02-13 Impact factor: 3.240
Authors: Boris Apodaca Michel; Miriam Navarro; Michael Pritsch; Jeremy Douglas Du Plessis; Jonathan Shock; Eva-Maria Schwienhorst-Stich; Janina Zirkel; Hanna Schrader; Claudia Saavedra Irala; Gonzalo Rubilar; Carolin Gunesch; Christa Kasang; Thomas Zoller; Ildiko Gagyor; Sandra Parisi Journal: BMJ Open Date: 2022-09-17 Impact factor: 3.006
Authors: Sandra Parisi; Miriam Navarro; Jeremy Douglas Du Plessis; Jonathan Phillip Shock; Boris Apodaca Michel; Minerva Lucuy Espinoza; Carolina Terán; Nino Antonio Calizaya Tapia; Katharina Oltmanns; Abundio Baptista Mora; Claudia Saveedra Irala; Angel Alberto Rivera Rojas; Gonzalo Rubilar; Thomas Zoller; Michael Pritsch Journal: PLoS Negl Trop Dis Date: 2020-10-29